89 related articles for article (PubMed ID: 1448772)
1. Multicentric evaluation of a new assay for prothrombin fragment F1+2 determination.
Bruhn HD; Conard J; Mannucci M; Monteagudo J; Pelzer H; Reverter JC; Samama M; Tripodi A; Wagner C
Thromb Haemost; 1992 Oct; 68(4):413-7. PubMed ID: 1448772
[TBL] [Abstract][Full Text] [Related]
2. Relationship between international normalized ratio values, vitamin K-dependent clotting factor levels and in vivo prothrombin activation during the early and steady phases of oral anticoagulant treatment.
D'Angelo A; Della Valle P; Crippa L; Fattorini A; Pattarini E; Viganò D'Angelo S
Haematologica; 2002 Oct; 87(10):1074-80. PubMed ID: 12368163
[TBL] [Abstract][Full Text] [Related]
3. Association between prothrombin activation fragment (F1.2), cerebral ischemia (S-100beta) and international normalized ratio (INR) in patients with ventricular assisted devices.
Joshi A; Magder LS; Kon Z; Kallam S; Kwon M; Sangrampurkar R; Pierson R; Poston R
Interact Cardiovasc Thorac Surg; 2007 Jun; 6(3):323-7. PubMed ID: 17669856
[TBL] [Abstract][Full Text] [Related]
4. [Evaluation of an enzyme-linked immunosorbent assay for the determination of prothrombin fragment F1.2 (Dade Prothrombin Fragment F1.2 ELISA: Baxter Diagnostics Inc., U.S.A.) using micro-titer plate].
Suzuki T; Amano K; Kuroso K; Fukutake K; Fujimaki M
Rinsho Byori; 1993 Feb; 41(2):215-9. PubMed ID: 8361024
[TBL] [Abstract][Full Text] [Related]
5. [Evaluation of plasma prothrombin fragment 1+2 in healthy donors and thrombotic diseases].
Kawai Y; Shiomi T; Ono H; Katagiri H; Uchida R; Sugisaki N; Watanabe K
Rinsho Byori; 1994 Jan; 42(1):57-62. PubMed ID: 8107284
[TBL] [Abstract][Full Text] [Related]
6. Levels of prothrombin fragment F1+2 in patients with hyperhomocysteinemia and a history of venous thromboembolism.
Kyrle PA; Stümpflen A; Hirschl M; Bialonczyk C; Herkner K; Speiser W; Weltermann A; Kaider A; Pabinger I; Lechner K; Eichinger S
Thromb Haemost; 1997 Nov; 78(5):1327-31. PubMed ID: 9408013
[TBL] [Abstract][Full Text] [Related]
7. Effect of different oral anticoagulant intensities on prothrombin fragment 1 + 2 in Thai patients with mechanical heart valve prostheses.
Tientadakul P; Opartkiattikul N; Sangtawesin W; Sakiyalak P
J Med Assoc Thai; 1997 Feb; 80(2):81-6. PubMed ID: 9078691
[TBL] [Abstract][Full Text] [Related]
8. [Measurement of prothrombin fragment F1+2 for monitoring the anticoagulant effect of phenprocoumon].
Bruhn HD; Zurborn KH
Dtsch Med Wochenschr; 1993 Jul; 118(26):967-70. PubMed ID: 8519230
[TBL] [Abstract][Full Text] [Related]
9. Reactivation of coagulation after stopping infusions of recombinant hirudin and unfractionated heparin in unstable angina and myocardial infarction without ST elevation: results of a randomized trial. OASIS Pilot Study Investigators. Organization to Assess Strategies for Ischemic++ Syndromes.
Flather MD; Weitz JI; Yusuf S; Pogue J; Sussex B; Campeau J; Gill J; Schuld R; Joyner CD; Morris AL; Lai C; Théroux P; Marquis JF; Chan YK; Venkatesh G; Jessel A
Eur Heart J; 2000 Sep; 21(17):1473-81. PubMed ID: 10952840
[TBL] [Abstract][Full Text] [Related]
10. Determination of human prothrombin activation fragment 1 + 2 in plasma with an antibody against a synthetic peptide.
Pelzer H; Schwarz A; Stüber W
Thromb Haemost; 1991 Feb; 65(2):153-9. PubMed ID: 2053101
[TBL] [Abstract][Full Text] [Related]
11. Influence of long term oral anticoagulants upon prothrombin fragment 1 + 2, thrombin-antithrombin III complex and D-Dimer levels in patients affected by proximal deep vein thrombosis.
Elias A; Bonfils S; Daoud-Elias M; Gauthier B; Sié P; Boccalon H; Boneu B
Thromb Haemost; 1993 Apr; 69(4):302-5. PubMed ID: 8497840
[TBL] [Abstract][Full Text] [Related]
12. Standardization of prothrombin fragment 1.2 measurement: effects of preanalytical variables and calibrator selection.
Hursting MJ; Slaughter TF; Stead AG; Szewczyk KM; Witt DJ; Greenberg CS
Arch Pathol Lab Med; 1998 Jan; 122(1):31-6. PubMed ID: 9448013
[TBL] [Abstract][Full Text] [Related]
13. [Comparative multicenter study of a rabbit high-sensitivity thromboplastin and a recombinant thromboplastin with synthetic phospholipids].
Martínez-Brotóns F; Borrell M; Fontcuberta J; Batlle J; López F; Páramo JA; Ribera C; Rocha E; Vicente V; Zuazu I
Sangre (Barc); 1994 Aug; 39(4):245-51. PubMed ID: 7985052
[TBL] [Abstract][Full Text] [Related]
14. Determination of prothrombin activation fragments in young patients with inflammatory bowel disease.
Smith CJ; Haire WD; Kaufman SS; Mack DR
Am J Gastroenterol; 1996 Jun; 91(6):1221-5. PubMed ID: 8651175
[TBL] [Abstract][Full Text] [Related]
15. The use of prothrombin fragment F1+2 to monitor the effect of oral anticoagulation.
Bruhn HD; Zurborn KH
J Heart Valve Dis; 1995 Mar; 4(2):138-40. PubMed ID: 8556173
[TBL] [Abstract][Full Text] [Related]
16. Early decrease in coagulation activity after myocardial infarction is associated with lower risk of new ischaemic events: observations from the ESTEEM Trial.
Christersson C; Oldgren J; Bylock A; Siegbahn A; Wallentin L
Eur Heart J; 2007 Mar; 28(6):692-8. PubMed ID: 17314111
[TBL] [Abstract][Full Text] [Related]
17. Hypercoagulability state in patients with chronic obstructive pulmonary disease. Chronic Obstructive Bronchitis and Haemostasis Group.
Alessandri C; Basili S; Violi F; Ferroni P; Gazzaniga PP; Cordova C
Thromb Haemost; 1994 Sep; 72(3):343-6. PubMed ID: 7855781
[TBL] [Abstract][Full Text] [Related]
18. New trends in the field of coagulation diagnosis--new possibilities to improve monitoring of antithrombotic therapy.
Pelzer H; Stüber W; Dati F; Heimburger N
Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(6):867-71. PubMed ID: 2483704
[TBL] [Abstract][Full Text] [Related]
19. Clinical utility of prothrombin fragment 1+2, thrombin antithrombin III complexes and D-dimer measurements in the diagnosis of deep vein thrombosis following total hip replacement.
Cofrancesco E; Cortellaro M; Corradi A; Ravasi F; Bertocchi F
Thromb Haemost; 1998 Mar; 79(3):509-10. PubMed ID: 9531030
[TBL] [Abstract][Full Text] [Related]
20. [Is the assessment of prothrombin fragment F1+2 for monitoring of heparin therapy in patients with deep vein thrombosis useful?].
Korte W; Corbetta C; Schmid L
Schweiz Med Wochenschr; 1995 Mar; 125(9):420-3. PubMed ID: 7892570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
